medigraphic.com
ISSN 1405-8871 (Print)

2021, Number 1

<< Back Next >>

Aten Fam 2021; 28 (1)

Hypervitaminosis B12 and Mortality at Advanced Ages

García RAM, Sánchez VMJ, González MI, Villaescusa FC, Alonso DFA, Sánchez GE

Language: Spanish
References: 20
Page: 26-32
PDF size: 163.32 Kb.


ABSTRACT

Objective: to study the cause of death and associated comorbidities in patients with hypervitaminosis B12 and with altered laboratory parameters. Methods: cross-sectional study. Information was taken from 156 dead people diagnosed with hypervitaminosis B12 from 2016 to 2019, patients with previous tumors were excluded. B12 product was analyzed by CRP index (vitamin B12/C-reactive protein Index). Sex, age, day and cause of exitus, associated pathologies and concomitant analytical alterations were taken as study variables. The results were expressed in percentages and means; the CRP was expressed in or and 95% CI. Results: a mortality of 10.5% was detected, average age 78.42, B12 1441 pg/ml and mean of 158 days at the moment of death. Vitamin B12 value was related to age and sex (p=0.025). The presence of neoplasms was 37%; of which digestive tumors were presented in 29.7% and metastases in 21.2%; with respect to the presence of infectious causes was in 15%, of which pneumonia was manifested in 58%, sepsis in 48%; and cardiac complications were 13.6%. The parameters with the greatest alteration were GGT (59%), ferritin (47.4%) and AF (41.7%). The CRP section ›40,000 occurred in 57% of the patients with a distance to death within one month. Conclusions: in presence of hypervitaminosis B12, men die before women, mainly due to digestive tumors, 50% before six months; men present high levels of ggt and ferritin in one of every two cases.


REFERENCES

  1. Zhang S-L, Chen T-S, Ma C-Y, Meng Y-B, Zhang Y-B, Yi-Wei Chen et al., Effect of vitamin B supplementation on cancer incidence, death due to cancer, and total mortality. Medicine. 2016;95(31):e3485.

  2. Callaghan FM, Leishear K, Abhyankar S, Demner- Fushman D, McDonald CJ. High vitamin B12 levels are not associated with increased mortality risk for ICU patients after adjusting for liver function: a cohort study. e SPEN J.2014;9:e76- e83.

  3. Dangour AD, Breeze E, Clarke R, Shetty PS, Uauy R, Fletcher AE. Plasma homocysteine, but not folate or vitamin B-12, predicts mortality in older people in the United Kingdom. J. Nutr. 2008;138:1121-1128.

  4. Geissbühler P, Mermillod B, Rapin C-H. Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: A prospective study over five years. J Pain Symptom Manage. 2000;20:93-103.

  5. Arendt JF, Pedersen L, Nexo E, Sorensen HT. Elevated plasma vitamin B12 levels as a marker for cancer: a population-based cohort study. J. Natl. Cancer Inst. 2013;105:1799-1805.

  6. García Rodríguez AM, Sánchez Velasco M et al. Hipervitaminosis B12 y cáncer de recto. Rev Lab Clin. 2017;10(2):105-108.

  7. García Rodríguez AM, Sánchez Velasco M, Fernández García N, Garrote Adrados JA. Hipervitaminosis B12: reactante y biomarcador en cáncer. Aten Prim Prac. 2019;1(3):45-49.

  8. Sviri S, Khalaila R, Daher S, et al. Increased vitamin B12 levels are associated with mortality in critically ill medical patients. Clin Nutr. 2012;31:53-9.

  9. Hemmersbach-Miller M, Conde-Martel A, Betancor-Leon P. Vitamin B12 as a predictor of mortality in elderly patients.J. Am. Geriatr. Soc. 2005;53:2035-2036.

  10. Baztan JJ, Gavidia JJ, Gomez-Pavon J, Esteve UN, Ruiperez I. Altos niveles de vitamina b12 y mortalidad hospitalaria. J Am Geriatr Assoc. 2010;58:223-8.

  11. Salles N, Herrmann F, Sieber C, Rapin C. High vitamin B12 level and mortality in elderly inpatients. JNHA. 2008;12:219.

  12. Tal S, Guller V, Shavit Y, Stern F, Malnick S. Mortality predictors in hospitalized elderly patients QJM: An International Journal of Medicine. 2011;104(11):933-938.

  13. Capello S, Cereda E, Rondanelli M, Klersy C, Cameletti b, Albertinni R. et all. Elevated Plasma Vitamin B12 Concentrations Are Independent Predictors of In-Hospital Mortality in Adult Patients at Nutritional Risk Nutrientes. 2017;9(1):1.

  14. Lin CY, Kuo CS, Lu CL, Wu MY, Huang RF. Elevated serum vitamin B12 levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma.Nutr. Cancer. 2010;62:190-197.

  15. Kelly L, White S, Stone PC. The B12/CRP index as a simple prognostic indicator in patients with advanced cancer: a confirmatory study. Ann Oncol. 2007;18:1395-9.

  16. Zulfiqar A-A, Andrés E, Lorenzo Villalba N. Hipervitaminosis B12 . Nuestra experiencia y una revisión. Medicina (Buenos Aires). 2019;79: 391- 396.

  17. Ebbing M, Bnaa KH, Nyga rd O et al. Cancer incidence and mortalityafter treatment with folic acid and vitamin B12. JAMA. 2009;302:2119-2

  18. Zhang SM, Willett WC, Selhub J, et al. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst. 2003;95(5):373-380.

  19. Kim YI, Salomon RN, Graeme-Cook F, et al. Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut. 1996;39:732-740.

  20. Flores-Guerrero JL, Minović I, Groothof D, Gruppen EG, Riphagen IJ, Kootstra-Ros J, et al. Association of Plasma Concentration of Vitamin B12 With All-Cause Mortality in the General Population in the Netherlands. JAMA Network Open. 2020;3(1):e1919274.




2020     |     www.medigraphic.com